OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • February 27th, 2020 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • New York
CytomX Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.00001 per share (the “Common Shares”), having an aggregate offering price of up to $75,000,000 on the terms set forth in this agreement (this “Agreement”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • February 27th, 2020 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of February 3, 2020 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Alison Hannah, M.D. (“Employee”).
